-
1. Ziegler D.: Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab. Res. Rev., 2008, 24, 52-7.
-
2. Singh U., Jialal I.: Alpha-lipoic acid supplementation and diabetes. Nutr. Rev., 2008, 66, 11, 646-57.
-
3. Burekovic A., Terzić M., Alajbegovic S., et al.: The role of alpha-lipoic acid in diabetic polyneuropathy treatment. Bosn. J. Basic Med. Sci., 2008, 8, 4, 341-5.
-
4. Varko- nyi T., Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obes. Metab., 2008, 10, 2, 99-108.
-
5. Foster T.S.: Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ., 2007, 33, 1, 111-7.
-
6. Bloch-Damti A., Bashan N.: Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox. Signal., 2005, 7, 11-12, 1553-67.
-
7. Vincent A.M., McLean L.L., Backus C., et al.: Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J., 2005, 19, 6, 638-40.
-
8. Huang E.A, Gitelman S.E.: The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus. Pediatr. Diabetes., 2008, 9, 69-73.
-
9. Gonzalez-Perez O., Moy-López N.A., Guzman- Muńiz J.: Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine. Rev. Invest. Clin., 2008, 60, 1, 58-67.
-
10. Obrosova I.G., Fathallah L., Liu E., et al.: Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid. Free Radie. Biol. Med., 2003, 34, 2, 186-95.